|
ROIV
|
US |
ROIVANT SCIENCES LTD |
3,508,694 |
$42M |
8.30% |
16.0%
|
- |
|
PTGX
|
US |
PROTAGONIST THERAPEUTICS INC |
1,020,333 |
$39M |
7.87% |
-86.5%
|
- |
|
BOXX
|
US |
ALPHA ARCHITECT 1-3 MNTH BOX |
325,450 |
$36M |
7.17% |
0.6%
|
- |
|
ZLAB
|
US |
ZAI LAB LTD-ADR |
1,045,837 |
$27M |
5.47% |
96.4%
|
- |
|
IMVT
|
US |
IMMUNOVANT INC |
787,478 |
$20M |
3.90% |
7620.4%
|
- |
|
CYTK
|
US |
CYTOKINETICS INC |
414,209 |
$19M |
3.89% |
-
|
- |
|
BBIO
|
US |
BRIDGEBIO PHARMA INC |
678,857 |
$19M |
3.72% |
-53.1%
|
- |
|
IKT
|
US |
INHIBIKASE THERAPEUTICS INC |
5,103,005 |
$17M |
3.31% |
100.0%
|
- |
|
BIL
|
US |
SPDR BLOOMBERG 1-3 MONTH T-B |
131,786 |
$12M |
2.41% |
504.9%
|
- |
|
ABVX
|
US |
ABIVAX SA-ADR |
1,513,393 |
$11M |
2.21% |
190.1%
|
- |
|
MLYS
|
US |
MINERALYS THERAPEUTICS INC |
841,541 |
$10M |
2.07% |
15.4%
|
- |
|
ASND
|
US |
ASCENDIS PHARMA A/S - ADR |
71,402 |
$10M |
1.96% |
-55.8%
|
- |
|
PCSC
|
US |
PERCEPTIVE CAPITAL SOLUTIONS |
750,000 |
$8M |
1.53% |
-
|
- |
|
RVMD
|
US |
REVOLUTION MEDICINES INC |
170,000 |
$7M |
1.49% |
283.3%
|
- |
|
RZLT
|
US |
REZOLUTE INC |
1,359,208 |
$7M |
1.33% |
-13.5%
|
- |
|
EDR
|
US |
ENDEAVOR GROUP HOLD-CLASS A |
210,729 |
$7M |
1.32% |
71.6%
|
- |
|
CGON
|
US |
CG ONCOLOGY INC |
215,750 |
$6M |
1.24% |
50.8%
|
- |
|
03675P102
|
- |
ANTERIS TECHNOLOGIES GLOBAL |
1,052,968 |
$6M |
1.17% |
100.0%
|
- |
|
AAM
|
US |
AA MISSION ACQUISITION COR-A |
560,199 |
$6M |
1.13% |
-44.5%
|
- |
|
CHRS 1.5 04/15/26
|
TRACE |
COHERUS BIOSCIENCES INC |
5,625,000 |
$5M |
1.09% |
100.0%
|
- |